Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

New compounds may help treat prostate issues without affecting androgen receptors.

The FDA rejected a testosterone drug again due to safety concerns.

Herbal formula shows promise for hair loss treatment.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The "Flavosterol" emulgel meets quality standards for treating hair loss.

A new compound effectively inhibits human 5α-reductase 1.

The hydrogel with Finasteride provides controlled, sustained drug release and improved bioavailability.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Androgens and estrogens are crucial for insulin secretion in males.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

A new minoxidil-like substance, triaminodil, was found in an illegal hair growth supplement.

Clascoterone is safe for the heart, even at high doses.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

The β-sitosterol hair gel is effective and promising for treating hair loss.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Beard hair follicles convert testosterone to 5α-dihydrotestosterone most intensively.

Created tablet similar to Avodart using γ-cyclodextrin and solubilizers.

Human liver enzyme DHEA ST helps process minoxidil.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Nanostructured lipid carriers can improve androgenic alopecia treatment by reducing dutasteride dosage and maintaining its presence in hair follicles longer.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

New steroids were effective in blocking male hormone receptors in hamster prostates.

New method accurately measures finasteride and M3 in urine, helping evaluate pharmacokinetics.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.